You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 10, October 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HLA Class I and Class II Antigen Expression on Squamous Cell Carcinoma of the Head and Neck

John R. Houck, MD; F. Mack Sexton, MD; Grazyna Zajdel

Arch Otolaryngol Head Neck Surg. 1990;116(10):1181-1185.


Abstract

• We compared human major histocompatibility (HLA) class I and class II antigen expression on squamous cell carcinoma of the head and neck with that on normal mucosa. Frozen sections of a consecutive series of 30 squamous cell carcinomas were stained with the monoclonal antibodies W6/32 (class I) and anti-DR (class II) using an immunoperoxidase technique. Normal mucosa showed class I and class II expression in the basal layers only. Class I expression on tumors was diffuse in 87%, patchy in 10%, and scattered in 3%. Class II expression on tumors was diffuse in 20%, patchy in 53%, scattered in 20%, and absent in 7%. Patterns of expression did not correlate significantly with clinical parameters, including survival, except that class II diffuse and patchy patterns were found to correlate with more poorly differentiated tumors.

(Arch Otolaryngol Head Neck Surg. 1990;116:1181-1185)



Author Affiliations

From the Division of Otolaryngology—Head and Neck Surgery (Dr Houck and Ms Zajdel) and the Department of Pathology (Dr Sexton), The Pennsylvania State University, The Milton S. Hershey Medical Center. Dr Houck is now in private practice in Oklahoma City, Okla.


Footnotes

Accepted for publication May 15, 1990.

Presented in part at the Second International Conference on Head and Neck Cancer, Boston, Mass, August 2, 1988.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HLA Class I Antigen Down-regulation in Primary Laryngeal Squamous Cell Carcinoma Lesions as a Poor Prognostic Marker.
Ogino et al.
Cancer Res. 2006;66:9281-9289.
ABSTRACT | FULL TEXT  

Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome
Meissner et al.
Clin. Cancer Res. 2005;11:2552-2560.
ABSTRACT | FULL TEXT  

Association of Tapasin and HLA Class I Antigen Down-Regulation in Primary Maxillary Sinus Squamous Cell Carcinoma Lesions with Reduced Survival of Patients
Ogino et al.
Clin. Cancer Res. 2003;9:4043-4051.
ABSTRACT | FULL TEXT  

Impairment of T-Cell Activation in Head and Neck Cancer In Situ and In Vitro: Strategies for an Immune Restoration
Lang et al.
Arch Otolaryngol Head Neck Surg 1999;125:82-88.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.